Core Viewpoint - The pork industry is facing significant pressure due to declining prices, with various companies reporting decreased sales revenue and a potential shift in policy aimed at stabilizing prices and improving profitability in the sector [1][2][3]. Group 1: Company Performance - In May, TianKang Biological (002100) sold 229,700 pigs, generating sales revenue of 345 million yuan, with an average selling price of 14.02 yuan/kg [1]. - From January to May, TianKang Biological sold a total of 1.2851 million pigs, a year-on-year increase of 12.49%, with cumulative sales revenue of 1.902 billion yuan, up 4.22% from the previous year [1]. - Despite low pork prices, TianKang Biological managed to keep its breeding costs below 13 yuan/kg, allowing for profitability even with market prices at 14.02 yuan/kg [2]. Group 2: Industry Trends - As of June 10, the wholesale price of pork has dropped to 20.3 yuan/kg, a decrease of 9.21% since the end of last year and nearly 27% from the peak in August of the previous year [1]. - The national pig-to-grain price ratio has been declining, falling from 7.95 yuan/kg to 6.29 yuan/kg, nearing the warning line for excessive decline [1]. - The government has initiated a reserve mechanism, with a plan to store 10,000 tons of frozen pork, marking the first storage action since 2025 [2]. Group 3: Market Outlook - Analysts predict that if recent policies to stabilize pork prices are fully implemented, the pig farming industry could return to normal profitability by 2025, with cost-competitive companies likely to achieve excess returns [2]. - The overall valuation of the pig farming sector is at historical lows, with the Shenyin Wanguo pig farming sector's price-to-earnings ratio below the 10th percentile historically [3]. - TianKang Biological's current rolling P/E ratio is 12.45, the lowest in the pig farming sector, indicating potential for growth as the market stabilizes [3].
天康生物前5月生猪销售收入同比增长4.22%,公司最新市盈率仅12倍,出海业务实现“0”到“1”的突破